Skip to main content
Erschienen in: neurogenetics 4/2006

01.11.2006 | Original Article

Familial risks of hospitalization for Parkinson’s disease in first-degree relatives: a nationwide follow-up study from Sweden

verfasst von: Kristina Sundquist, Xinjun Li, Kari Hemminki

Erschienen in: Neurogenetics | Ausgabe 4/2006

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to estimate familial risks of Parkinson’s disease (PD) in first-degree relatives of probands with PD compared with first-degree relatives of control probands. Standardized incidence ratios (SIRs) of PD were estimated in the total Swedish population for the period January 1, 1987 to December 31, 2001. SIRs were calculated by age, sex, occupation, geographic region, family size, and type of related proband on the basis of first hospital diagnoses of PD during the study period. Results showed that during the study period, there were 65 cases of first-degree relatives who were hospitalized for PD out of the total 13,276 events (first hospital diagnoses of PD) between 1987 and 2001. Age-specific analyses of familial PD revealed that there was no apparent difference in SIRs by age category. Overall, significant SIRs for PD in first-degree relatives were 3.1 (95% CI 2.1-4.3) for men and 4.0 (95% CI 2.8-5.7) for women. When the related PD proband was a sibling, the SIR was significantly higher (8.7) than when the related proband was a parent (SIR=2.9, p=0.01) or a child (SIR=3.6, p=0.04). For spouses, no increased risks were found. In conclusion, the findings of the present study suggest that genetic factors are important in early- (age ≤50 years) and later (age >50 years) onset PD, and that shared environmental factors during childhood or recessive effects may partly be important for familial aggregation of the disease.
Literatur
1.
Zurück zum Zitat Sveinbjornsdottir S, Hicks AA, Jonsson T, Petursson H, Gugmundsson G, Frigge ML, Kong A, Gulcher JR, Stefansson K (2000) Familial aggregation of Parkinson’s disease in Iceland. N Engl J Med 343:1765–1770PubMedCrossRef Sveinbjornsdottir S, Hicks AA, Jonsson T, Petursson H, Gugmundsson G, Frigge ML, Kong A, Gulcher JR, Stefansson K (2000) Familial aggregation of Parkinson’s disease in Iceland. N Engl J Med 343:1765–1770PubMedCrossRef
2.
Zurück zum Zitat Payami H, Zareparsi S, James D, Nutt J (2002) Familial aggregation of Parkinson disease: a comparative study of early-onset and late-onset disease. Arch Neurol 59:848–850PubMedCrossRef Payami H, Zareparsi S, James D, Nutt J (2002) Familial aggregation of Parkinson disease: a comparative study of early-onset and late-onset disease. Arch Neurol 59:848–850PubMedCrossRef
3.
Zurück zum Zitat Marder K, Levy G, Louis ED, Mejia-Santana H, Cote L, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Ottman R (2003) Familial aggregation of early- and late-onset Parkinson’s disease. Ann Neurol 54:507–513PubMedCrossRef Marder K, Levy G, Louis ED, Mejia-Santana H, Cote L, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Ottman R (2003) Familial aggregation of early- and late-onset Parkinson’s disease. Ann Neurol 54:507–513PubMedCrossRef
4.
Zurück zum Zitat Semchuk KM, Love EJ, Lee RG (1993) Parkinson’s disease: a test of the multifactorial etiologic hypothesis. Neurology 43:1173–1180PubMed Semchuk KM, Love EJ, Lee RG (1993) Parkinson’s disease: a test of the multifactorial etiologic hypothesis. Neurology 43:1173–1180PubMed
5.
Zurück zum Zitat Payami H, Larsen K, Bernard S, Nutt J (1994) Increased risk of Parkinson’s disease in parents and siblings of patients. Ann Neurol 36:659–661PubMedCrossRef Payami H, Larsen K, Bernard S, Nutt J (1994) Increased risk of Parkinson’s disease in parents and siblings of patients. Ann Neurol 36:659–661PubMedCrossRef
6.
Zurück zum Zitat Marder K, Tang MX, Mejia H, Alfaro B, Cote L, Louis E, Groves J, Mayeux R (1996) Risk of Parkinson’s disease among first-degree relatives: A community-based study. Neurology 47:155–160PubMed Marder K, Tang MX, Mejia H, Alfaro B, Cote L, Louis E, Groves J, Mayeux R (1996) Risk of Parkinson’s disease among first-degree relatives: A community-based study. Neurology 47:155–160PubMed
7.
Zurück zum Zitat Autere JM, Moilanen JS, Myllyla VV, Majamaa K (2000) Familial aggregation of Parkinson’s disease in a Finnish population. J Neurol Neurosurg Psychiatry 69:107–109PubMedCrossRef Autere JM, Moilanen JS, Myllyla VV, Majamaa K (2000) Familial aggregation of Parkinson’s disease in a Finnish population. J Neurol Neurosurg Psychiatry 69:107–109PubMedCrossRef
8.
Zurück zum Zitat Hicks AA, Petursson H, Jonsson T, Stefansson H, Johannsdottir HS, Sainz J, Frigge ML, Kong A, Gulcher JR, Stefansson K, Sveinbjornsdottir S (2002) A susceptibility gene for late-onset idiopathic Parkinson’s disease. Ann Neurol 52:549–555PubMedCrossRef Hicks AA, Petursson H, Jonsson T, Stefansson H, Johannsdottir HS, Sainz J, Frigge ML, Kong A, Gulcher JR, Stefansson K, Sveinbjornsdottir S (2002) A susceptibility gene for late-onset idiopathic Parkinson’s disease. Ann Neurol 52:549–555PubMedCrossRef
9.
Zurück zum Zitat Piccini P, Burn DJ, Ceravolo R, Maraganore D, Brooks DJ (1999) The role of inheritance in sporadic Parkinson’s disease: evidence from a longitudinal study of dopaminergic function in twins. Ann Neurol 45:577–582PubMedCrossRef Piccini P, Burn DJ, Ceravolo R, Maraganore D, Brooks DJ (1999) The role of inheritance in sporadic Parkinson’s disease: evidence from a longitudinal study of dopaminergic function in twins. Ann Neurol 45:577–582PubMedCrossRef
10.
Zurück zum Zitat Tanner CM, Ottman R, Goldman SM, Ellenberg J, Chan P, Mayeux R, Langston JW (1999) Parkinson disease in twins: an etiologic study. Jama 281:341–346PubMedCrossRef Tanner CM, Ottman R, Goldman SM, Ellenberg J, Chan P, Mayeux R, Langston JW (1999) Parkinson disease in twins: an etiologic study. Jama 281:341–346PubMedCrossRef
11.
Zurück zum Zitat Polymeropoulos MH, Higgins JJ, Golbe LI, Johnson WG, Ide SE, Di Iorio G, Sanges G, Stenroos ES, Pho LT, Schaffer AA, Lazzarini AM, Nussbaum RL, Duvoisin RC (1996) Mapping of a gene for Parkinson’s disease to chromosome 4q21–q23. Science 274:1197–1199PubMedCrossRef Polymeropoulos MH, Higgins JJ, Golbe LI, Johnson WG, Ide SE, Di Iorio G, Sanges G, Stenroos ES, Pho LT, Schaffer AA, Lazzarini AM, Nussbaum RL, Duvoisin RC (1996) Mapping of a gene for Parkinson’s disease to chromosome 4q21–q23. Science 274:1197–1199PubMedCrossRef
12.
Zurück zum Zitat Funayama M, Hasegawa K, Kowa H, Saito M, Tsuji S, Obata F (2002) A new locus for Parkinson’s disease (PARK8) maps to chromosome 12p11.2–q13.1. Ann Neurol 51:296–301PubMedCrossRef Funayama M, Hasegawa K, Kowa H, Saito M, Tsuji S, Obata F (2002) A new locus for Parkinson’s disease (PARK8) maps to chromosome 12p11.2–q13.1. Ann Neurol 51:296–301PubMedCrossRef
13.
Zurück zum Zitat Elbaz A, Grigoletto F, Baldereschi M, Breteler MM, Manubens-Bertran JM, Lopez-Pousa S, Dartigues JF, Alperovitch A, Tzourio C, Rocca WA (1999) Familial aggregation of Parkinson’s disease: a population-based case-control study in Europe. EUROPARKINSON Study Group. Neurology 52:1876–1882PubMed Elbaz A, Grigoletto F, Baldereschi M, Breteler MM, Manubens-Bertran JM, Lopez-Pousa S, Dartigues JF, Alperovitch A, Tzourio C, Rocca WA (1999) Familial aggregation of Parkinson’s disease: a population-based case-control study in Europe. EUROPARKINSON Study Group. Neurology 52:1876–1882PubMed
14.
Zurück zum Zitat Rybicki BA, Johnson CC, Peterson EL, Kortsha GX, Gorell JM (1999) A family history of Parkinson’s disease and its effect on other PD risk factors. Neuroepidemiology 18:270–278PubMedCrossRef Rybicki BA, Johnson CC, Peterson EL, Kortsha GX, Gorell JM (1999) A family history of Parkinson’s disease and its effect on other PD risk factors. Neuroepidemiology 18:270–278PubMedCrossRef
15.
Zurück zum Zitat Hemminki K, Vaittinen P, Dong C, Easton D (2001) Sibling risks in cancer: clues to recessive or X-linked genes? Br J Cancer 84:388–391PubMedCrossRef Hemminki K, Vaittinen P, Dong C, Easton D (2001) Sibling risks in cancer: clues to recessive or X-linked genes? Br J Cancer 84:388–391PubMedCrossRef
16.
Zurück zum Zitat Petrovitch H, Ross GW, Abbott RD, Sanderson WT, Sharp DS, Tanner CM, Masaki KH, Blanchette PL, Popper JS, Foley D, Launer L, White LR (2002) Plantation work and risk of Parkinson disease in a population-based longitudinal study. Arch Neurol 59:1787–1792PubMedCrossRef Petrovitch H, Ross GW, Abbott RD, Sanderson WT, Sharp DS, Tanner CM, Masaki KH, Blanchette PL, Popper JS, Foley D, Launer L, White LR (2002) Plantation work and risk of Parkinson disease in a population-based longitudinal study. Arch Neurol 59:1787–1792PubMedCrossRef
17.
Zurück zum Zitat Gorell JM, Peterson EL, Rybicki BA, Johnson CC (2004) Multiple risk factors for Parkinson’s disease. J Neurol Sci 217:169–174PubMedCrossRef Gorell JM, Peterson EL, Rybicki BA, Johnson CC (2004) Multiple risk factors for Parkinson’s disease. J Neurol Sci 217:169–174PubMedCrossRef
18.
Zurück zum Zitat Frigerio R, Elbaz A, Sanft KR, Peterson BJ, Bower JH, Ahlskog JE, Grossardt BR, de Andrade M, Maraganore DM, Rocca WA (2005) Education and occupations preceding Parkinson disease: a population-based case-control study. Neurology 65:1575–1583PubMedCrossRef Frigerio R, Elbaz A, Sanft KR, Peterson BJ, Bower JH, Ahlskog JE, Grossardt BR, de Andrade M, Maraganore DM, Rocca WA (2005) Education and occupations preceding Parkinson disease: a population-based case-control study. Neurology 65:1575–1583PubMedCrossRef
19.
Zurück zum Zitat Wirdefeldt K, Gatz M, Schalling M, Pedersen NL (2004) No evidence for heritability of Parkinson disease in Swedish twins. Neurology 63:305–311PubMed Wirdefeldt K, Gatz M, Schalling M, Pedersen NL (2004) No evidence for heritability of Parkinson disease in Swedish twins. Neurology 63:305–311PubMed
20.
Zurück zum Zitat McDonnell SK, Schaid DJ, Elbaz A, Strain KJ, Bower JH, Ahlskog JE, Maraganore DM, Rocca WA (2006) Complex segregation analysis of Parkinson’s disease: The Mayo Clinic Family Study. Ann Neurol 59:788–795PubMedCrossRef McDonnell SK, Schaid DJ, Elbaz A, Strain KJ, Bower JH, Ahlskog JE, Maraganore DM, Rocca WA (2006) Complex segregation analysis of Parkinson’s disease: The Mayo Clinic Family Study. Ann Neurol 59:788–795PubMedCrossRef
21.
Zurück zum Zitat Zorzon M, Capus L, Pellegrino A, Cazzato G, Zivadinov R (2002) Familial and environmental risk factors in Parkinson’s disease: a case-control study in north-east Italy. Acta Neurol Scand 105:77–82PubMedCrossRef Zorzon M, Capus L, Pellegrino A, Cazzato G, Zivadinov R (2002) Familial and environmental risk factors in Parkinson’s disease: a case-control study in north-east Italy. Acta Neurol Scand 105:77–82PubMedCrossRef
22.
Zurück zum Zitat Taylor CA, Saint-Hilaire MH, Cupples LA, Thomas CA, Burchard AE, Feldman RG, Myers RH (1999) Environmental, medical, and family history risk factors for Parkinson’s disease: a New England-based case control study. Am J Med Genet 88:742–749PubMedCrossRef Taylor CA, Saint-Hilaire MH, Cupples LA, Thomas CA, Burchard AE, Feldman RG, Myers RH (1999) Environmental, medical, and family history risk factors for Parkinson’s disease: a New England-based case control study. Am J Med Genet 88:742–749PubMedCrossRef
23.
Zurück zum Zitat Rocca WA, McDonnell SK, Strain KJ, Bower JH, Ahlskog JE, Elbaz A, Schaid DJ, Maraganore DM (2004) Familial aggregation of Parkinson’s disease: The Mayo Clinic family study. Ann Neurol 56:495–502PubMedCrossRef Rocca WA, McDonnell SK, Strain KJ, Bower JH, Ahlskog JE, Elbaz A, Schaid DJ, Maraganore DM (2004) Familial aggregation of Parkinson’s disease: The Mayo Clinic family study. Ann Neurol 56:495–502PubMedCrossRef
25.
Zurück zum Zitat Farrer MJ (2006) Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet 7:306–318PubMedCrossRef Farrer MJ (2006) Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet 7:306–318PubMedCrossRef
26.
Zurück zum Zitat The National Board of Health and Welfare (2000) Validity of the diagnoses from the Swedish In-Care register 1987 and 1995 (In Swedish: Värdering av diagnoskvaliteten för akut hjärtinfarkt i patientregistret 1987 och 1995). In, Epidemiologiskt Centrum, Socialstyrelsen, http://www.sos.se/epc/pdf/rapp8795.pdf The National Board of Health and Welfare (2000) Validity of the diagnoses from the Swedish In-Care register 1987 and 1995 (In Swedish: Värdering av diagnoskvaliteten för akut hjärtinfarkt i patientregistret 1987 och 1995). In, Epidemiologiskt Centrum, Socialstyrelsen, http://​www.​sos.​se/​epc/​pdf/​rapp8795.​pdf
27.
Zurück zum Zitat Rosen M, Hakulinen T (2005) Use of disease registers. In: Ahrens W, Pigeot I (eds) Handbook of epidemiology. Springer, Berlin Heidelberg New York Rosen M, Hakulinen T (2005) Use of disease registers. In: Ahrens W, Pigeot I (eds) Handbook of epidemiology. Springer, Berlin Heidelberg New York
28.
Zurück zum Zitat Lazzarini AM, Myers RH, Zimmerman TR Jr, Mark MH, Golbe LI, Sage JI, Johnson WG, Duvoisin RC (1994) A clinical genetic study of Parkinson’s disease: evidence for dominant transmission. Neurology 44:499–506PubMed Lazzarini AM, Myers RH, Zimmerman TR Jr, Mark MH, Golbe LI, Sage JI, Johnson WG, Duvoisin RC (1994) A clinical genetic study of Parkinson’s disease: evidence for dominant transmission. Neurology 44:499–506PubMed
Metadaten
Titel
Familial risks of hospitalization for Parkinson’s disease in first-degree relatives: a nationwide follow-up study from Sweden
verfasst von
Kristina Sundquist
Xinjun Li
Kari Hemminki
Publikationsdatum
01.11.2006
Verlag
Springer-Verlag
Erschienen in
Neurogenetics / Ausgabe 4/2006
Print ISSN: 1364-6745
Elektronische ISSN: 1364-6753
DOI
https://doi.org/10.1007/s10048-006-0055-z

Weitere Artikel der Ausgabe 4/2006

neurogenetics 4/2006 Zur Ausgabe

Acknowledgement to Referees

Acknowledgement to Referees 2005–2006

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.